Suchergebnisse - "Tarantino, Paolo"

PubPharm (12)

1

Next-generation antibody-drug conjugates for breast cancer : Moving beyond HER2 and TROP2

enthalten in: Critical reviews in oncology/hematology | 2023

von Schlam, I. | Moges, R. | Morganti, S. | +2

2

Optimizing the safety of antibody-drug conjugates for patients with solid tumours

enthalten in: Nature reviews. Clinical oncology | 2023

von Tarantino, P. | Ricciuti, B. | Pradhan, S. | +1

3

HER2-low expression in breast oncology : treatment implications in the smart chemotherapy era

enthalten in: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) | 2023

von Giugliano, F. | Curigliano, G. | Tarantino, P.

4

How I treat HER2-low advanced breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Schlam, I. | Tolaney, S. | Tarantino, P.

5

Biology and Treatment of HER2-Low Breast Cancer

enthalten in: Hematology/oncology clinics of North America | 2023

von Nicolò, E. | Tarantino, P. | Curigliano, G.

6

Lessons from recent trials of antibody-drug conjugates in breast cancer

enthalten in: Clinical advances in hematology & oncology : H&O | 2022

von Tarantino, P.

7

The Dawn of the Antibody-Drug Conjugates Era : How T-DM1 Reinvented the Future of Chemotherapy for Solid Tumors

enthalten in: Cancer research | 2022

von Tarantino, P. | Tolaney, S.

CommentOn: Cancer Res. 2008 Nov 15;68(22):9280-90. - PMID 19010901

8

Navigating the HER2-Low Paradigm in Breast Oncology : New Standards, Future Horizons

enthalten in: Cancer discovery | 2022

von Tarantino, P. | Curigliano, G. | Tolaney, S.

9

Bystander effect of antibody-drug conjugates : fact or fiction?

enthalten in: Current oncology reports | 2022

von Giugliano, F. | Corti, C. | Tarantino, P. | +2

10

Antibody-drug conjugates : Smart chemotherapy delivery across tumor histologies

enthalten in: CA: a cancer journal for clinicians | 2022

von Tarantino, P. | Carmagnani Pestana, R. | Corti, C. | +6